Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Preskorn · SciRah

Researcher profile · Semantic Scholar

S. Preskorn

Share profile

S. Preskorn — researcher profile on SciRah

h-index: 53
Works: 415
Citations: 10K

Most-cited papers

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
M. Fedgchin, M. Trivedi, E. Daly, R. Melkote +14 more
2019International Journal of Neuropsychopharmacology411 citations Open access
Semantic Scholar
Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent.
S. Preskorn, M. Macaluso, Do Vishaal Mehra, G. Zammit +2 more
2015Journal of Psychiatric Practice175 citations
Semantic Scholar
Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition: A Proof of Concept, Randomized Trial in Patients with Schizophrenia
S. Preskorn, M. Gawryl, N. Dgetluck, M. Palfreyman +2 more
2014Journal of Psychiatric Practice134 citations
Semantic Scholar
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
J. Savitz, T. Teague, Masaya Misaki, M. Macaluso +7 more
2018Translational Psychiatry131 citations Open access
Semantic Scholar
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.
S. Preskorn, S. Zeller, L. Citrome, Jeffrey Finman +6 more
2022Journal of the American Medical Association (JAMA)81 citations Open access
Semantic Scholar
Lurasidone drug-drug interaction studies: a comprehensive review
Y. Chiu, L. Ereshefsky, S. Preskorn, N. Poola +1 more
2014Drug Metabolism and Drug Interactions47 citations Open access
Semantic Scholar
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy
S. Preskorn
2020Journal of Psychiatric Practice34 citations Open access
Semantic Scholar
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
L. Citrome, S. Preskorn, J. Lauriello, J. Krystal +6 more
2022Journal of Clinical Psychiatry23 citations Open access
Semantic Scholar
How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study Enrollment
S. Preskorn, M. Macaluso, M. Trivedi
2015Journal of Psychiatric Practice21 citations
Semantic Scholar
A Way of Conceptualizing Benzodiazepines to Guide Clinical Use
S. Preskorn
2015Journal of Psychiatric Practice20 citations
Semantic Scholar
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
A. Breier, R. Buchanan, D. D'Souza, K. Nuechterlein +21 more
2019Schizophrenia Research17 citations
Semantic Scholar
The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional Stimuli
Kymberly D. Young, S. Preskorn, Teresa A. Victor, Masaya Misaki +2 more
2016International Journal of Neuropsychopharmacology17 citations Open access
Semantic Scholar
Clinical pharmacology in the development of new antidepressants: the challenges.
R. Alexander, S. Preskorn
2014Current opinion in pharmacology (Print)15 citations
Semantic Scholar
Tardive Dyskinesia: A Historical Perspective
M. Macaluso, A. Flynn, S. Preskorn
2017Journal of Psychiatric Practice13 citations
Semantic Scholar
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles
S. Preskorn
2022Journal of Psychiatric Practice12 citations
Semantic Scholar
Letter to the Editor: Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed?
J. Goldberg, J. Rosenblat, R. McIntyre, S. Preskorn +1 more
2019Journal of Psychiatric Research12 citations
Semantic Scholar
Drug-drug Interactions in Psychiatric Practice, Part 1: Reasons, Importance, and Strategies to Avoid and Recognize Them.
S. Preskorn
2018Journal of Psychiatric Practice12 citations
Semantic Scholar
CNS Drug Development: Lessons from the Development of Ondansetron, Aprepitant, Ramelteon, Varenicline, Lorcaserin, and Suvorexant. Part I
S. Preskorn
2014Journal of Psychiatric Practice12 citations
Semantic Scholar
How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications
S. Preskorn
2022Journal of Psychiatric Practice11 citations
Semantic Scholar
The role of proof of concept (POC) studies in drug development using the EVP-6124 POC study as an example.
S. Preskorn
2014Journal of Psychiatric Practice11 citations
Semantic Scholar
Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression.
David J. Williamson, J. Gogate, Jennifer K. Kern Sliwa, L. Manera +4 more
2022Journal of Clinical Psychiatry10 citations Open access
Semantic Scholar
How Loading Dose Strategies for Depot Paliperidone Can Go Wrong.
S. Preskorn
2022Journal of Psychiatric Practice10 citations
Semantic Scholar
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 3: Pharmacokinetic Considerations
S. Preskorn
2019Journal of Psychiatric Practice10 citations
Semantic Scholar
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant—Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism
S. Preskorn
2023Journal of Psychiatric Practice9 citations
Semantic Scholar
COVID-19: Why Has the Mortality Rate Declined?
S. Preskorn
2020Journal of Psychiatric Practice8 citations
Semantic Scholar
Knowledge of the Pharmacology of Antidepressants and Antipsychotics Yields Results Comparable With Pharmacogenetic Testing
M. Macaluso, S. Preskorn
2018Journal of Psychiatric Practice8 citations
Semantic Scholar
Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions?
S. Preskorn, Syed Quadri
2020Journal of Psychiatric Practice7 citations
Semantic Scholar
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 Enzymes
S. Preskorn
2020Journal of Psychiatric Practice7 citations
Semantic Scholar
CNS Drug Development, Lessons Learned, Part 5: How Preclinical and Human Safety Studies Inform the Approval and Subsequent Use of a New Drug—Suvorexant as an Example
S. Preskorn
2018Journal of Psychiatric Practice7 citations
Semantic Scholar
High false-positive rate of a putative biomarker test to aid in the diagnosis of schizophrenia.
Cheryl A. Wehler, S. Preskorn
2016Journal of Clinical Psychiatry7 citations
Semantic Scholar
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies
M. Macaluso, A. Flynn, S. Preskorn
2016Journal of Psychiatric Practice7 citations
Semantic Scholar
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1
S. Preskorn, A. Flynn, M. Macaluso
2015Journal of Psychiatric Practice7 citations
Semantic Scholar
CNS Drug Development: Lessons Learned Part 2. Symptoms, Not Syndromes as Targets Consistent with the NIMH Research Domain Approach
S. Preskorn
2015Journal of Psychiatric Practice7 citations
Semantic Scholar
Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development.
S. Preskorn
2019Handbook of Experimental Pharmacology6 citations
Semantic Scholar
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data
S. Preskorn, M. Macaluso
2016Journal of Psychiatric Practice6 citations
Semantic Scholar
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data
M. Macaluso, A. Flynn, S. Preskorn
2016Journal of Psychiatric Practice6 citations
Semantic Scholar
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 2: Strategies to Minimize Adverse Outcomes From Unintended DDIs.
S. Preskorn
2018Journal of Psychiatric Practice5 citations
Semantic Scholar
CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes—Tasimelteon as an Example
S. Preskorn
2017Journal of Psychiatric Practice5 citations
Semantic Scholar
CNS Drug Development: Lessons Learned Part 3 Psychiatric and Central Nervous System Drugs Developed Over the Last Decade—Implications for the Field
S. Preskorn
2017Journal of Psychiatric Practice5 citations
Semantic Scholar
Switching From the Oral to the Depot Formulation of a Medication: Clinically Relevant Pharmacokinetic Concepts and Considerations
S. Preskorn
2017Journal of Psychiatric Practice5 citations
Semantic Scholar
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example.
M. Macaluso, A. Nichols, S. Preskorn
2015The Primary Care Companion For CNS Disorders5 citations Open access
Semantic Scholar
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression
C. Conway, A. Rush, C. Gordon, S. Preskorn +8 more
2025Journal of mood and anxiety disorders4 citations Open access
Semantic Scholar
Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases
S. Preskorn, David D. Masolak
2024Journal of Psychiatric Practice4 citations
Semantic Scholar
Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine
S. Preskorn, R. Rode
2023Journal of Psychiatric Practice4 citations
Semantic Scholar
Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug Development
S. Preskorn
2022Journal of Psychiatric Practice4 citations
Semantic Scholar
Drug-drug Interactions in Psychiatric Practice, Part 4: Classification of Neuropsychiatric Medications Based on Their Principal Mechanisms of Action (With Updated Neuroscience-based Nomenclature).
S. Preskorn, Alexander Germann
2019Journal of Psychiatric Practice4 citations
Semantic Scholar
Use of an Analog Scale in the Treatment of Patients With Major Depressive Disorder to Optimize Assessment and Clinical Outcome
S. Preskorn
2016Journal of Psychiatric Practice4 citations
Semantic Scholar
Genetic and Related Laboratory Tests in Psychiatry: What Mental Health Practitioners Need to Know
S. Preskorn
20164 citations
Semantic Scholar
From the Washington University (or Feighner) Psychiatric Diagnostic Criteria to DSM-III and Subsequent Versions: A Personal Perspective
S. Preskorn
2025Journal of Psychiatric Practice3 citations
Semantic Scholar
Charting and Handling Therapeutic Drug Monitoring Results: How they Differ From Most Laboratory Results
S. Preskorn
2021Journal of Psychiatric Practice3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Macaluso×11
Invite
M. Macaluso — researcher profile on SciRah
A. Flynn×4
Invite
A. Flynn — researcher profile on SciRah
R. Kakar×3
Invite
R. Kakar — researcher profile on SciRah
M. Trivedi×2
Invite
M. Trivedi — researcher profile on SciRah

×2

Invite

E. Daly — researcher profile on SciRah

Invite

M. Fava — researcher profile on SciRah

Invite

W. Drevets — researcher profile on SciRah

Masaya Misaki×2

Invite

Masaya Misaki — researcher profile on SciRah

B. E. Wurfel×2

Invite

B. E. Wurfel — researcher profile on SciRah

Invite

L. Citrome — researcher profile on SciRah

Jeffrey Finman×2

Invite

Jeffrey Finman — researcher profile on SciRah

Invite

J. Goldberg — researcher profile on SciRah